Therapeutic options in peripheral T cell lymphoma

Abstract Peripheral T cell lymphoma (PTCL) is a rare and heterogeneous group of non-Hodgkin lymphomas with a very poor prognosis. The standard first-line treatments have resulted in unsatisfactory patient outcomes. With the exception of low-risk anaplastic lymphoma kinase (ALK)-positive anaplastic l...

Full description

Bibliographic Details
Main Authors: Yaping Zhang, Wei Xu, Hong Liu, Jianyong Li
Format: Article
Language:English
Published: BMC 2016-04-01
Series:Journal of Hematology & Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13045-016-0267-0